standard]
MVAVAIDKDKGSQAALKWAVDHLLAKGKSVALLHVKQKTSAPLGNHADGG
KVALDNQAKELFLPFRCFCTRKDIQVNEVLLEDTDIARSLCDYVKNNNIE
HLVVGASVKSGFVRRFKTADIPGNVSKLAPEFCTVYVISKGKAASIRAAS
GGPTKEGSRSLHNAPDPRYMQSNGTRGGPMSPFAGRTVPTEEVDSIKSPF
TRGKANRSFGELSMTDSDISFVSSGRPSSDRMMSALEQDMMMAPRLSSSS
DTENRLSFGSPFARSSDANSSFGVYSSSSNESGNFSWSGSQSLEDVEAEM
RRLKQELKQTMDMYSSACKEALTAKQKAMELHRWKVEEQQRLEEARLAEE
AALAIAEKEKEKCRAAIEKAEAAQRIAELEAQKRINAEMKALKEAEEKKK
VMDKLAKNDVRYRKYTIEEIEAATEFFTKSRKIGEGGYGPVYKCYLDHTE
VAVKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPEYGCLVYEYM
ANGSLDDCLFRRGNTPVLPWQLRFRIAAEIGTGLLFLHQTKPEPLVHRDL
KPGNILLDRNFVSKISDVGLARLVPPSVADTVTQYRMTATAGTFCYIDPE
YQQTGMLGIKSDVYSLGVMLLQIITAKPPMGLTHHVDRAIEKGTFADMLD
PEVLDWPIEEALIFAKLALKCTELRRKDRPDLGTVVLPELNRLRSLAEET
MPSFSVNTSPRKVSAVRGSHSHVIESEKLYSGPDNIAKGRTLTAYNPARS
METYNS
|
IPR000719; Protein kinase, catalytic domain IPR002290; Serine/threonine-protein kinase domain IPR006016; UspA IPR008271; Serine/threonine-protein kinase, active site IPR017442; Serine/threonine-protei |